Concepts (243)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pseudomonas Phages | 2 | 2021 | 10 | 0.990 |
Why?
|
| Sewage | 2 | 2021 | 4 | 0.860 |
Why?
|
| Rivers | 2 | 2021 | 11 | 0.850 |
Why?
|
| beta-Lactamases | 4 | 2020 | 179 | 0.850 |
Why?
|
| Klebsiella Infections | 2 | 2018 | 64 | 0.780 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 3 | 2020 | 202 | 0.650 |
Why?
|
| Embolism | 1 | 2018 | 59 | 0.620 |
Why?
|
| Fluorodeoxyglucose F18 | 3 | 2014 | 1226 | 0.620 |
Why?
|
| Klebsiella pneumoniae | 1 | 2018 | 98 | 0.610 |
Why?
|
| Foreign-Body Migration | 1 | 2018 | 117 | 0.590 |
Why?
|
| Wounds, Gunshot | 1 | 2018 | 102 | 0.580 |
Why?
|
| Positron-Emission Tomography | 3 | 2014 | 2173 | 0.500 |
Why?
|
| Phage Therapy | 3 | 2024 | 23 | 0.480 |
Why?
|
| Intensive Care Units | 1 | 2018 | 717 | 0.460 |
Why?
|
| Cardiac Catheterization | 1 | 2018 | 687 | 0.460 |
Why?
|
| Heart Ventricles | 1 | 2018 | 846 | 0.440 |
Why?
|
| Veins | 1 | 2013 | 157 | 0.430 |
Why?
|
| Microbiota | 3 | 2024 | 547 | 0.430 |
Why?
|
| Iran | 8 | 2022 | 68 | 0.420 |
Why?
|
| Whole Body Imaging | 1 | 2013 | 114 | 0.420 |
Why?
|
| Anti-Bacterial Agents | 7 | 2024 | 2992 | 0.420 |
Why?
|
| Endovascular Procedures | 1 | 2018 | 516 | 0.400 |
Why?
|
| Colistin | 2 | 2022 | 33 | 0.390 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2018 | 7551 | 0.380 |
Why?
|
| Helicobacter pylori | 4 | 2019 | 1295 | 0.380 |
Why?
|
| Multimodal Imaging | 2 | 2014 | 550 | 0.360 |
Why?
|
| Pseudomonas Infections | 2 | 2021 | 156 | 0.350 |
Why?
|
| Pseudomonas aeruginosa | 2 | 2021 | 233 | 0.340 |
Why?
|
| Probiotics | 2 | 2023 | 228 | 0.330 |
Why?
|
| Microbial Sensitivity Tests | 5 | 2022 | 994 | 0.280 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2007 | 324 | 0.270 |
Why?
|
| Gastrointestinal Microbiome | 3 | 2024 | 907 | 0.270 |
Why?
|
| Alzheimer Disease | 2 | 2024 | 855 | 0.260 |
Why?
|
| Organometallic Compounds | 2 | 2015 | 191 | 0.240 |
Why?
|
| Surgical Wound | 1 | 2024 | 48 | 0.230 |
Why?
|
| Antigens, Bacterial | 2 | 2019 | 354 | 0.210 |
Why?
|
| Host Specificity | 1 | 2021 | 19 | 0.200 |
Why?
|
| Complementary Therapies | 1 | 2023 | 126 | 0.200 |
Why?
|
| Environmental Microbiology | 1 | 2021 | 22 | 0.200 |
Why?
|
| Mouth | 1 | 2022 | 122 | 0.200 |
Why?
|
| Tonsillitis | 1 | 2020 | 16 | 0.190 |
Why?
|
| Lactobacillus plantarum | 1 | 2020 | 5 | 0.190 |
Why?
|
| Fibroblasts | 1 | 2007 | 1682 | 0.190 |
Why?
|
| Bacterial Proteins | 3 | 2020 | 1029 | 0.190 |
Why?
|
| Genome, Viral | 1 | 2021 | 155 | 0.190 |
Why?
|
| Palatine Tonsil | 1 | 2020 | 53 | 0.190 |
Why?
|
| Burns | 1 | 2021 | 117 | 0.180 |
Why?
|
| Helicobacter Infections | 3 | 2019 | 1216 | 0.180 |
Why?
|
| Mesenteric Ischemia | 1 | 2020 | 12 | 0.180 |
Why?
|
| Embolization, Therapeutic | 2 | 2019 | 551 | 0.180 |
Why?
|
| Bone Neoplasms | 1 | 2013 | 2576 | 0.180 |
Why?
|
| Cross-Sectional Studies | 7 | 2020 | 4314 | 0.180 |
Why?
|
| Acinetobacter Infections | 1 | 2020 | 28 | 0.180 |
Why?
|
| Bacterial Infections | 1 | 2024 | 479 | 0.180 |
Why?
|
| Mesentery | 1 | 2020 | 72 | 0.180 |
Why?
|
| Acinetobacter baumannii | 1 | 2020 | 52 | 0.180 |
Why?
|
| Mesenteric Veins | 1 | 2020 | 73 | 0.180 |
Why?
|
| Radial Artery | 1 | 2019 | 50 | 0.170 |
Why?
|
| Oxazolidinones | 1 | 2019 | 60 | 0.170 |
Why?
|
| Tetrazoles | 1 | 2019 | 106 | 0.170 |
Why?
|
| Nalidixic Acid | 1 | 2018 | 3 | 0.170 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 222 | 0.170 |
Why?
|
| Clavulanic Acid | 1 | 2018 | 9 | 0.170 |
Why?
|
| Recombination, Genetic | 1 | 2021 | 613 | 0.160 |
Why?
|
| Imipenem | 1 | 2018 | 23 | 0.160 |
Why?
|
| Venous Cutdown | 1 | 2018 | 3 | 0.160 |
Why?
|
| Stomach Diseases | 1 | 2019 | 62 | 0.160 |
Why?
|
| Leiomyoma | 1 | 2019 | 145 | 0.160 |
Why?
|
| Femoral Artery | 1 | 2019 | 210 | 0.160 |
Why?
|
| Klebsiella | 1 | 2018 | 8 | 0.160 |
Why?
|
| Adhesins, Bacterial | 1 | 2019 | 85 | 0.160 |
Why?
|
| Anti-Infective Agents | 1 | 2022 | 446 | 0.160 |
Why?
|
| Nervous System Diseases | 1 | 2023 | 500 | 0.160 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2021 | 418 | 0.160 |
Why?
|
| Computed Tomography Angiography | 1 | 2020 | 234 | 0.160 |
Why?
|
| Femoral Vein | 1 | 2018 | 66 | 0.160 |
Why?
|
| Interleukin-17 | 1 | 2019 | 250 | 0.160 |
Why?
|
| Catheterization, Peripheral | 1 | 2019 | 158 | 0.150 |
Why?
|
| Amoxicillin | 1 | 2018 | 106 | 0.150 |
Why?
|
| beta-Lactamase Inhibitors | 1 | 2018 | 52 | 0.150 |
Why?
|
| Molecular Epidemiology | 1 | 2018 | 246 | 0.150 |
Why?
|
| Humans | 34 | 2024 | 261506 | 0.150 |
Why?
|
| Colitis | 1 | 2020 | 340 | 0.150 |
Why?
|
| Tertiary Care Centers | 1 | 2018 | 403 | 0.140 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2019 | 308 | 0.140 |
Why?
|
| Germanium | 1 | 2015 | 7 | 0.140 |
Why?
|
| Radiochemistry | 1 | 2015 | 7 | 0.140 |
Why?
|
| Adjuvants, Immunologic | 1 | 2019 | 657 | 0.140 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2019 | 673 | 0.130 |
Why?
|
| Mental Disorders | 1 | 2023 | 862 | 0.130 |
Why?
|
| Uterine Neoplasms | 1 | 2019 | 545 | 0.130 |
Why?
|
| Stomach Neoplasms | 1 | 2007 | 2278 | 0.130 |
Why?
|
| DNA, Bacterial | 2 | 2020 | 558 | 0.130 |
Why?
|
| Radioisotopes | 1 | 2015 | 177 | 0.130 |
Why?
|
| Bacteria | 3 | 2024 | 611 | 0.130 |
Why?
|
| Plasmids | 1 | 2016 | 837 | 0.120 |
Why?
|
| Adult | 16 | 2022 | 77950 | 0.120 |
Why?
|
| Saliva | 2 | 2005 | 231 | 0.120 |
Why?
|
| Receptors, Somatostatin | 1 | 2014 | 85 | 0.120 |
Why?
|
| Digestive System Neoplasms | 1 | 2014 | 82 | 0.120 |
Why?
|
| Phlebography | 1 | 2013 | 76 | 0.120 |
Why?
|
| Octreotide | 1 | 2014 | 118 | 0.120 |
Why?
|
| Male | 17 | 2020 | 123000 | 0.120 |
Why?
|
| Apoptosis | 1 | 2007 | 7591 | 0.110 |
Why?
|
| Contrast Media | 1 | 2020 | 1472 | 0.110 |
Why?
|
| Pandemics | 1 | 2022 | 1559 | 0.110 |
Why?
|
| Genetic Variation | 1 | 2021 | 2086 | 0.110 |
Why?
|
| Nasal Polyps | 1 | 2011 | 27 | 0.100 |
Why?
|
| Urease | 1 | 2011 | 60 | 0.100 |
Why?
|
| Nasal Mucosa | 1 | 2011 | 94 | 0.100 |
Why?
|
| Middle Aged | 15 | 2020 | 86204 | 0.100 |
Why?
|
| Radiation Dosage | 1 | 2015 | 1014 | 0.100 |
Why?
|
| Polymerase Chain Reaction | 2 | 2020 | 3203 | 0.100 |
Why?
|
| Aged | 10 | 2024 | 70117 | 0.090 |
Why?
|
| Escherichia coli | 1 | 2016 | 1203 | 0.090 |
Why?
|
| Female | 18 | 2020 | 141928 | 0.090 |
Why?
|
| Cystic Duct | 1 | 2008 | 10 | 0.080 |
Why?
|
| Adenocarcinoma | 1 | 2007 | 7789 | 0.080 |
Why?
|
| Diagnosis, Differential | 3 | 2013 | 4744 | 0.080 |
Why?
|
| Phylogeny | 2 | 2021 | 826 | 0.080 |
Why?
|
| Radiopharmaceuticals | 1 | 2014 | 1301 | 0.080 |
Why?
|
| Cholecystectomy, Laparoscopic | 1 | 2008 | 68 | 0.080 |
Why?
|
| Densitometry | 1 | 2007 | 45 | 0.080 |
Why?
|
| Neuroendocrine Tumors | 1 | 2014 | 634 | 0.080 |
Why?
|
| Neoplasms | 1 | 2013 | 15193 | 0.070 |
Why?
|
| Adolescent | 5 | 2020 | 31252 | 0.070 |
Why?
|
| Olfaction Disorders | 1 | 2006 | 26 | 0.070 |
Why?
|
| Thyroid Diseases | 1 | 2007 | 85 | 0.070 |
Why?
|
| Genes, Recessive | 1 | 2007 | 200 | 0.070 |
Why?
|
| Species Specificity | 1 | 2007 | 777 | 0.070 |
Why?
|
| Calcium Phosphates | 1 | 2006 | 19 | 0.070 |
Why?
|
| Urinary Calculi | 1 | 2006 | 25 | 0.070 |
Why?
|
| Calcium Oxalate | 1 | 2006 | 33 | 0.070 |
Why?
|
| Immunoblotting | 1 | 2007 | 886 | 0.070 |
Why?
|
| Case-Control Studies | 4 | 2022 | 6100 | 0.070 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2006 | 305 | 0.070 |
Why?
|
| Craniocerebral Trauma | 1 | 2006 | 130 | 0.070 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2007 | 144 | 0.070 |
Why?
|
| Proteinuria | 1 | 2006 | 155 | 0.060 |
Why?
|
| Treatment Outcome | 4 | 2020 | 32848 | 0.060 |
Why?
|
| Allopurinol | 1 | 2004 | 54 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2013 | 7702 | 0.060 |
Why?
|
| Aged, 80 and over | 3 | 2020 | 29902 | 0.060 |
Why?
|
| Epidermal Growth Factor | 1 | 2005 | 423 | 0.060 |
Why?
|
| Risk | 1 | 2007 | 1972 | 0.060 |
Why?
|
| Aggregatibacter actinomycetemcomitans | 1 | 2022 | 4 | 0.050 |
Why?
|
| Bone Density | 1 | 2005 | 476 | 0.050 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2022 | 62 | 0.050 |
Why?
|
| Antioxidants | 1 | 2005 | 507 | 0.050 |
Why?
|
| Survival Analysis | 1 | 2013 | 9180 | 0.050 |
Why?
|
| Laboratories | 1 | 2023 | 145 | 0.050 |
Why?
|
| Child, Preschool | 1 | 2018 | 16273 | 0.050 |
Why?
|
| Nitric Oxide | 1 | 2005 | 644 | 0.050 |
Why?
|
| Prevalence | 2 | 2020 | 3260 | 0.050 |
Why?
|
| Genotyping Techniques | 1 | 2021 | 166 | 0.050 |
Why?
|
| Dextran Sulfate | 1 | 2020 | 72 | 0.050 |
Why?
|
| Colony Count, Microbial | 1 | 2020 | 149 | 0.050 |
Why?
|
| Disease Outbreaks | 1 | 2023 | 415 | 0.050 |
Why?
|
| Surgical Wound Infection | 1 | 2024 | 450 | 0.050 |
Why?
|
| Hepatocyte Nuclear Factor 3-gamma | 1 | 2019 | 6 | 0.050 |
Why?
|
| Child | 2 | 2018 | 29154 | 0.050 |
Why?
|
| Carbapenems | 1 | 2020 | 62 | 0.040 |
Why?
|
| Punctures | 1 | 2019 | 104 | 0.040 |
Why?
|
| Coinfection | 1 | 2021 | 189 | 0.040 |
Why?
|
| Bacteriological Techniques | 1 | 2020 | 121 | 0.040 |
Why?
|
| Interleukin-18 | 1 | 2019 | 100 | 0.040 |
Why?
|
| Young Adult | 4 | 2020 | 21445 | 0.040 |
Why?
|
| Interleukin-4 | 1 | 2019 | 284 | 0.040 |
Why?
|
| Haplotypes | 1 | 2021 | 856 | 0.040 |
Why?
|
| Body Height | 1 | 2019 | 231 | 0.040 |
Why?
|
| RNA, Viral | 1 | 2021 | 671 | 0.040 |
Why?
|
| Th2 Cells | 1 | 2019 | 257 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2004 | 1129 | 0.040 |
Why?
|
| Th1 Cells | 1 | 2019 | 250 | 0.040 |
Why?
|
| Th17 Cells | 1 | 2019 | 162 | 0.040 |
Why?
|
| Neoplasm Staging | 1 | 2013 | 13658 | 0.040 |
Why?
|
| Mutation | 3 | 2023 | 15179 | 0.040 |
Why?
|
| Virulence | 1 | 2019 | 323 | 0.040 |
Why?
|
| Biopsy | 2 | 2019 | 3443 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2005 | 830 | 0.040 |
Why?
|
| Interleukin-8 | 1 | 2019 | 519 | 0.040 |
Why?
|
| Interleukins | 1 | 2019 | 325 | 0.040 |
Why?
|
| Evolution, Molecular | 1 | 2021 | 834 | 0.040 |
Why?
|
| Colon | 1 | 2020 | 670 | 0.040 |
Why?
|
| Staphylococcus aureus | 1 | 2020 | 548 | 0.030 |
Why?
|
| Interleukin-2 | 1 | 2019 | 842 | 0.030 |
Why?
|
| Ion Exchange | 1 | 2015 | 8 | 0.030 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2013 | 5319 | 0.030 |
Why?
|
| Chemistry Techniques, Synthetic | 1 | 2015 | 13 | 0.030 |
Why?
|
| Genotype | 2 | 2019 | 4109 | 0.030 |
Why?
|
| Stomach | 1 | 2019 | 387 | 0.030 |
Why?
|
| Melanoma | 1 | 2013 | 5317 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2019 | 1021 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2020 | 2314 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2021 | 1529 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2022 | 2803 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2019 | 1144 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2020 | 1819 | 0.030 |
Why?
|
| Vaccines | 1 | 2019 | 389 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2004 | 1362 | 0.030 |
Why?
|
| Escherichia coli Infections | 1 | 2016 | 241 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2019 | 2927 | 0.030 |
Why?
|
| Staphylococcal Infections | 1 | 2019 | 672 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2008 | 5542 | 0.030 |
Why?
|
| Brain | 1 | 2006 | 4113 | 0.030 |
Why?
|
| Time Factors | 2 | 2019 | 12926 | 0.030 |
Why?
|
| Cytokines | 1 | 2022 | 2809 | 0.030 |
Why?
|
| Retrospective Studies | 4 | 2020 | 37905 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2007 | 14551 | 0.030 |
Why?
|
| Animals | 3 | 2024 | 59536 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2013 | 11538 | 0.020 |
Why?
|
| Neoplasm Grading | 1 | 2014 | 1742 | 0.020 |
Why?
|
| Sphincterotomy, Endoscopic | 1 | 2008 | 14 | 0.020 |
Why?
|
| Cholangiography | 1 | 2008 | 36 | 0.020 |
Why?
|
| Cholelithiasis | 1 | 2008 | 43 | 0.020 |
Why?
|
| Mice | 2 | 2020 | 34495 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 7222 | 0.020 |
Why?
|
| Vestibule, Labyrinth | 1 | 2007 | 45 | 0.020 |
Why?
|
| Thyroxine | 1 | 2007 | 116 | 0.020 |
Why?
|
| Thiobarbituric Acid Reactive Substances | 1 | 2005 | 16 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 4892 | 0.020 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2005 | 84 | 0.020 |
Why?
|
| Lipid Peroxidation | 1 | 2005 | 157 | 0.020 |
Why?
|
| Femur | 1 | 2005 | 158 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2011 | 14889 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 6207 | 0.020 |
Why?
|
| Postmenopause | 1 | 2005 | 378 | 0.010 |
Why?
|
| Syndrome | 1 | 2007 | 1351 | 0.010 |
Why?
|
| Reference Values | 1 | 2005 | 1099 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2011 | 5637 | 0.010 |
Why?
|
| Texas | 1 | 2014 | 6311 | 0.010 |
Why?
|
| Osteoporosis | 1 | 2005 | 241 | 0.010 |
Why?
|
| Disease Progression | 1 | 2014 | 6682 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 2005 | 417 | 0.010 |
Why?
|
| Risk Factors | 1 | 2019 | 17523 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2004 | 1323 | 0.010 |
Why?
|
| Incidence | 1 | 2011 | 5673 | 0.010 |
Why?
|
| Quality of Life | 1 | 2014 | 4532 | 0.010 |
Why?
|
| Chromosome Aberrations | 1 | 2007 | 1960 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2004 | 2588 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2005 | 2203 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2007 | 4320 | 0.010 |
Why?
|
| Prognosis | 1 | 2005 | 21713 | 0.000 |
Why?
|